Topic
Patent Validity
197 published works
China Law Insight
Introduction to the ten most significant cases of patent reexamination and invalidation in 2020 Medicinal part
By King & Wood
For the preparation patent and the use patent cases, decisions have demonstrated the idea of conducting examination based on comprehensive consideration of the background of the invention and the prior…
China Law Insight
2020年度专利复审·无效十大案件介绍 医药化学篇
By King & Wood
结合国家知识产权局一直以来的专利无效宣告请求的审查职能，药品专利权的有效性审查合并是否落入专利保护范围的行政裁决将迎来一个新的局面。在这样的大背景下，2020年国家知识产权局十大案件中的药品专利的决定对于行业有更实际和有效的指导意义，可以使公众更进一步地了解专利局对于药品专利有效性的评价思路。
Buchanan PTAB Report
IPRs Survive Supreme Court Scrutiny by Allowing USPTO Director to Review PTAB Decisions
The Supreme Court issued a decision today in U.S. v. Arthrex, Inc. upholding the use of inter partes reviews (IPRs) to challenge the validity of issued patents under the America Invents Act. While the…
Harness Dickey Blog
Intrinsic Evidence > Dictionary Definitions, Analogies, and Purported Plain Meaning
By Todd
In Uniloc 2017 LLC v. Apple Inc., [2020-1403, 2020-1404] (May 12, 2021), the Federal Circuit affirmed the PTAB determination that claims 1 – 17 and 23 – 25 of U.S. Patent No.…
China Law Insight
専利無効審判手続きにおける請求項の補正
By King & Wood
中国では、特許出願及び実用新案出願が権利付与された後、無効審判手続き以外、権利者は、請求項を自発的に補正する機会がない。無効審判が請求された後、権利者は、無効審判請求書及び証拠を受領してから一ヶ月以内に、無効審判請求に対して請求項を補正する機会がある。ただし、請求項の補正方式は、厳しく制限されている。
China Law Insight
Claim amendment in the patent invalidation proceeding
By King & Wood
In China, once a patent for invention or utility model has been granted, apart from the patent invalidation proceeding, the patentee does not have other opportunities to amend any claim…
China Law Insight
专利无效宣告程序中权利要求修改
By King & Wood
在中国，发明专利和实用新型专利获得授权后，除了无效宣告程序，权利人并没有其他主动修改权利要求的机会。在专利被提起无效宣告请求之后，权利人收到无效宣告请求书及证据的一个月内，权利人有机会针对无效宣告请求来修改权利要求，但是权利要求的修改方式受到严格限制。
Minding Your Business
When Is Less Really More for a Patent Licensee?
By Siegmund Y. Gutman, Chelsea L. Ostrer
In Apple v. Qualcomm, Federal Circuit Finds No Standing to Challenge Validity of a Few Patents When Many Were Licensed The development timeline for small-molecule drugs and biologics is lengthy,…
China Law Insight
化合物に関する特許の無効審判段階での安定性分析 – 3
By King & Wood
第三部分では主に、欧米及び中国の補足実験データに対する審査基準を比較し、これに基づき中国の審査実務に対し提案を行う。
The Trade Practitioner
Cross-post: Growing Tension Between the ITC and the PTAB
One of the most common responses to being sued for patent infringement is a petition to the USPTO’s Patent Trial and Appeal Board (PTAB) challenging the validity of the patent.…